OH HB682

Prohibits health insurers from requiring physician-administered drugs to be dispensed only by specific pharmacies or in-network pharmacies for patients with chronic, complex, rare, or life-threatening conditions

Bars insurers from limiting coverage or imposing additional fees based on a patient's choice of pharmacy for outpatient physician-administered drugs at physician offices or independent hospitals (those with under $2 billion annual revenue)

Requires patient informed consent and a physician attestation that delay won't increase health risk before insurers can shift billing from medical benefit to pharmacy benefit

Applies when a physician determines that care delays would cause disease progression, that using a network pharmacy would risk death or harm, or that timeliness/dosage needs require a different pharmacy

Takes effect for health benefit plans issued, amended, or renewed on or after January 1, 2027